1419 — Human Health Holdings Share Price
Last trade - 00:00- HK$371.96m
- HK$47.78m
- HK$1.00bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.49 | ||
| Price to Tang. Book | 0.51 | ||
| Price to Free Cashflow | 3.8 | ||
| Price to Sales | 0.6 | ||
| EV to EBITDA | 7.2 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -6.2% | ||
| Return on Equity | -8.1% | ||
| Operating Margin | -8.57% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 528.59 | 453.74 | 654.71 | 1,121.79 | 1,001.75 | n/a | n/a | 14.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +7.04 | n/a | n/a | +196.87 | -40.32 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Human Health Holdings Limited is a private integrated healthcare service provider in Hong Kong with comprehensive outpatient capabilities covering general practice services, specialties services and dental services. The Company's general practice services include a broad range of family medicine related healthcare services such as general consultation, diagnostic and preventative healthcare services, treatments, minor procedures, pharmaceutical drug dispensing, vaccinations, physical check-ups, health education activities, provision of occupational health advices and work injury assessment. Its specialties services include general surgery, orthopaedics & traumatology, ophthalmology, otorhinolaryngology, paediatrics surgery, obstetrics & gynaecology, cardiology, gastroenterology & hepatology, respiratory medicine and dermatology. Its dental services comprise general dentistry, specialties dentistry and cosmetic dentistry.
Directors
- Kin Ping Chan CHM (51)
- Chui Wan Sat CFO (48)
- Chun Pong Poon COO (38)
- Lai Sheung Pang EDR (48)
- Tat Ming Chan OTH (48)
- Wai Hong Chan OTH (49)
- Chi Wai Hui OTH (43)
- Wai Man Lau OTH (49)
- Siu Keung Seto OTH (49)
- Ka Sing Yuen OTH (44)
- Ching Yan Man SEC (33)
- Yue Kwong Chan NID (64)
- Sun Wing Lui NID (65)
- Kar Tim Sin NID (59)
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 9th, 2015
- Public Since
- April 1st, 2016
- No. of Employees
- 386
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 379,552,233
- Address
- 12th Floor, Enterprise Square Two
- Web
- https://humanhealth.com.hk/zh-hant/
- Phone
- +852 null39718266
- Auditors
- Ernst & Young
Upcoming Events for 1419
Similar to 1419
Adicon Holdings
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:11 UTC, shares in Human Health Holdings are trading at HK$0.98. This share price information is delayed by 15 minutes.
Shares in Human Health Holdings last closed at HK$0.98 and the price had moved by -52.2% over the past 365 days. In terms of relative price strength the Human Health Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -50.1% over the past year.
There is no consensus recommendation for this security.
The Human Health Holdings dividend yield is 16.33% based on the trailing twelve month period.
Last year, Human Health Holdings paid a total dividend of HK$0.16, and it currently has a trailing dividend yield of 16.33%. We do not have any data on when Human Health Holdings is to next pay dividends.
We do not have data on when Human Health Holdings is to next pay dividends. The historic dividend yield on Human Health Holdings shares is currently 16.33%.
To buy shares in Human Health Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.98, shares in Human Health Holdings had a market capitalisation of HK$371.96m.
Here are the trading details for Human Health Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1419
Based on an overall assessment of its quality, value and momentum Human Health Holdings is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Human Health Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -31.93%.
As of the last closing price of HK$0.98, shares in Human Health Holdings were trading -28.19% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Human Health Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.98.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Human Health Holdings' management team is headed by:
- Kin Ping Chan - CHM
- Chui Wan Sat - CFO
- Chun Pong Poon - COO
- Lai Sheung Pang - EDR
- Tat Ming Chan - OTH
- Wai Hong Chan - OTH
- Chi Wai Hui - OTH
- Wai Man Lau - OTH
- Siu Keung Seto - OTH
- Ka Sing Yuen - OTH
- Ching Yan Man - SEC
- Yue Kwong Chan - NID
- Sun Wing Lui - NID
- Kar Tim Sin - NID